Overmedicalisation: when medicine reaches too far
Overmedicalisation is medicalization taken too far: it is what happens when the process of turning ordinary life into medical conditions extends beyond the point where it helps and begins to cause harm. Medicalization itself, the defining of nonmedical problems as illnesses to be diagnosed and treated, is a neutral process that can be beneficial. Overmedicalisation is the value judgement that, in a particular case, the medical net has been cast so wide that healthy people are turned into patients, minor variations into diseases, and the risks and costs of medicine outweigh what it delivers.
Two meanings of “too much medicine”
The phrase “too much medicine” is used in two quite different ways, and it is worth separating them at the outset.
The first is the literal, individual sense: taking a larger dose of a drug than intended, such as too much of a cold remedy or a child’s medicine. That is a question of overdose and toxicity, where excess paracetamol can damage the liver and other drugs can strain the kidney, and it is a matter for a clinician, a pharmacist or a poisons information service, not for a reference article. This page does not give dosing or emergency advice; anyone worried about a specific dose should contact a health professional directly.
The second sense, and the subject here, is systemic: a whole society, or a whole area of care, receiving more medicine than is good for it. This is the meaning behind the BMJ‘s “Too Much Medicine” initiative and the international Preventing Overdiagnosis conference, both of which examine how modern healthcare can overreach. Overmedicalisation in this sense is not about one person’s pills but about where medicine as an institution draws its boundaries.
How medicine reaches too far
Overmedicalisation usually happens gradually, through several overlapping mechanisms rather than a single decision.
- Lowering thresholds. The cut-off for diagnosing a condition is moved so that more people qualify. When the numbers that define high blood pressure, high cholesterol or low bone density are set lower, millions of previously healthy people become patients overnight.
- Turning risk factors into diseases. Conditions such as prehypertension, prediabetes and osteopenia describe raised risk rather than present illness, yet they can be treated as diseases in their own right.
- Widening definitions. The boundaries of a recognised disorder expand to include milder and milder forms, a drift often called bracket creep.
- Screening the well. Testing large numbers of people without symptoms finds many small abnormalities, some of which would never have caused harm if left undiscovered.
Each mechanism can be reasonable in isolation. Together they tend to enlarge the population defined as sick or at risk, which is the engine of overmedicalisation.
Overdiagnosis and overtreatment
Overmedicalisation is closely tied to two more specific problems. Overdiagnosis means correctly identifying a condition that would never have caused symptoms or shortened life, so that the diagnosis itself brings no benefit. The physician H. Gilbert Welch examines this in his book Overdiagnosed: Making People Sick in the Pursuit of Health (2011), using screening for certain cancers as a leading example. Overtreatment is the natural sequel: once someone is diagnosed, they are likely to be treated, and treatment carries its own risks. A person overdiagnosed with a harmless abnormality can still undergo real surgery, radiation or lifelong medication, with all the side effects those entail. Overdiagnosis and overtreatment are, in effect, overmedicalisation seen at the level of the individual patient.
The costs of doing too much
Reaching too far with medicine is not a harmless surplus of care; it produces its own distinct harms.
- Physical harm from tests and treatments. Every drug has side effects and every procedure carries risk, so treating conditions that would never have caused trouble means accepting harm with no matching benefit.
- Psychological harm. Being labelled with a disease or a raised risk can create lasting anxiety and a sense of fragility, sometimes called the “disease” of being at risk.
- Financial and system cost. Money and clinical attention spent on unnecessary care are diverted from people with genuine, pressing needs.
- Cascades. One test often leads to another, and an incidental finding can set off a chain of follow-up investigations, each with its own risks.
These harms are the reason overmedicalisation is treated as a problem in its own right rather than simply as excess enthusiasm for health.
Responses to overmedicalisation
A number of organised efforts try to pull medicine back toward proportion. The Choosing Wisely campaign encourages clinicians and patients to question tests and treatments that are unlikely to help. The BMJ‘s “Too Much Medicine” series and the Preventing Overdiagnosis conference gather evidence on where healthcare overreaches. The idea of quaternary prevention, protecting patients from unnecessary or excessive medical intervention, gives clinicians a name for the duty to avoid doing too much. Writers such as Ray Moynihan, Iona Heath and H. Gilbert Welch have argued in different ways for a medicine that knows its own limits.
None of this amounts to a rejection of medicine. The point of naming overmedicalisation is not that care is bad, but that more is not always better, and that recognising the excess is part of using medicine well. Whether a given diagnosis or treatment is proportionate depends on the specific condition, the evidence behind it, and an honest weighing of its benefits against its harms.